Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA

Molecular Therapy - Nucleic Acids - Tập 29 - Trang 618-624 - 2022
Xijun Piao1, Vibha Yadav1, Eddie Wang1, Wayne Chang1, Lanna Tau1, Benjamin E. Lindenmuth1, Sharon X. Wang1
1Technical Development, Ultragenyx Pharmaceutical Inc., 5000 Marina Blvd., Brisbane, CA 94005, USA

Tài liệu tham khảo

Fortner, 2021, First COVID-19 vaccines receiving the US FDA and EMA emergency use authorization, Discoveries, 9, e122, 10.15190/d.2021.1 Jhaveri, 2021, The COVID-19 mRNA vaccines and the pandemic: do they represent the beginning of the end or the end of the beginning?, Clin. Ther., 43, 549, 10.1016/j.clinthera.2021.01.014 Pardi, 2018, mRNA vaccines — a new era in vaccinology, Nat. Rev. Drug Discov., 17, 261, 10.1038/nrd.2017.243 Karikó, 2005, Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA, Immunity, 23, 165, 10.1016/j.immuni.2005.06.008 Karikó, 2008, Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability, Mol. Ther., 16, 1833, 10.1038/mt.2008.200 Anderson, 2010, Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation, Nucleic Acids Res., 38, 5884, 10.1093/nar/gkq347 Vaidyanathan, 2018, Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without HPLC purification, Mol. Ther. Nucleic Acids, 12, 530, 10.1016/j.omtn.2018.06.010 Sikorski, 2020, The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells, Nucleic Acids Res., 48, 1607, 10.1093/nar/gkaa032 Karikó, 2011, Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA, Nucleic Acids Res., 39, e142, 10.1093/nar/gkr695 Weissman, 2013, HPLC purification of in vitro transcribed long RNA, Methods Mol. Biol., 969, 43, 10.1007/978-1-62703-260-5_3 Kalmakoff, 1973, A simple method for the separation of single-stranded and double-stranded RNA on hydroxyapatite, Anal. Biochem., 55, 26, 10.1016/0003-2697(73)90287-X Baiersdörfer, 2019, A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA, Mol. Ther. Nucleic Acids, 15, 26, 10.1016/j.omtn.2019.02.018 Foster, 2019, Purification of mRNA encoding chimeric antigen receptor is critical for generation of a robust T-cell response, Hum. Gene Ther., 30, 168, 10.1089/hum.2018.145 Kanwal, 2018, Large-scale in vitro transcription, RNA purification and chemical probing analysis, Cell. Physiol. Biochem., 48, 1915, 10.1159/000492512 Wu, 2020, Synthesis of low immunogenicity RNA with high-temperature in vitro transcription, RNA, 26, 345, 10.1261/rna.073858.119 Gholamalipour, 2019, Efficient inhibition of RNA self-primed extension by addition of competing 3’-capture DNA-improved RNA synthesis by T7 RNA polymerase, Nucleic Acids Res., 47, e118, 10.1093/nar/gkz700 Cavac, 2021, High-salt transcription of DNA cotethered with T7 RNA polymerase to beads generates increased yields of highly pure RNA, J. Biol. Chem., 297, 100999, 10.1016/j.jbc.2021.100999 Triana-Alonso, 1995, Self-coded 3′-extension of run-off transcripts produces aberrant products during in vitro transcription with T7 RNA polymerase, J. Biol. Chem., 270, 6298, 10.1074/jbc.270.11.6298 Gholamalipour, 2018, 3’ end additions by T7 RNA polymerase are RNA self-templated, distributive and diverse in character-RNA-Seq analyses, Nucleic Acids Res., 46, 9253, 10.1093/nar/gky796 Mu, 2018, An origin of the immunogenicity of in vitro transcribed RNA, Nucleic Acids Res., 46, 5239, 10.1093/nar/gky177 Nacheva, 2003, Preventing nondesired RNA-primed RNA extension catalyzed by T7 RNA polymerase, Eur. J. Biochem., 270, 1458, 10.1046/j.1432-1033.2003.03510.x Moqtaderi, 2014, Secondary structures involving the poly(A) tail and other 3’ sequences are major determinants of mRNA isoform stability in yeast, Microb. Cell, 1, 137, 10.15698/mic2014.04.140 Milligan, 1987, Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates, Nucleic Acids Res., 15, 8783, 10.1093/nar/15.21.8783 Martin, 1988, Processivity in early stages of transcription by T7 RNA polymerase, Biochemistry, 27, 3966, 10.1021/bi00411a012 Huang, 2000, Misincorporation by wild-type and mutant T7 RNA polymerases: identification of interactions that reduce misincorporation rates by stabilizing the catalytically incompetent open conformation, Biochemistry, 39, 11571, 10.1021/bi000579d Balachandran, 2000, Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection, Immunity, 13, 129, 10.1016/S1074-7613(00)00014-5 Nelson, 2020, Impact of mRNA chemistry and manufacturing process on innate immune activation, Sci. Adv., 6, eaaz6893, 10.1126/sciadv.aaz6893